On the public citation graph
Hypertension and non‐alcoholic fatty liver disease proven by transient elastography
0 signed · 77 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1002/hep.25762openalex-snapshot
The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association
inferredcites →https://doi.org/10.1016/j.atherosclerosis.2015.02.049openalex-snapshot
Metabolic syndrome and its components as predictors of nonalcoholic fatty liver disease in a northern urban Han Chinese population: A prospective cohort study
inferredcites →https://doi.org/10.1016/j.cgh.2008.11.005openalex-snapshot
Long-Term Follow-Up of Patients With Nonalcoholic Fatty Liver
inferredcites →https://doi.org/10.1016/j.cgh.2011.03.020openalex-snapshot
Changes in the Prevalence of the Most Common Causes of Chronic Liver Diseases in the United States From 1988 to 2008
inferredcites →https://doi.org/10.1016/j.mce.2015.02.018openalex-snapshot
Metabolic syndrome and nonalcoholic fatty liver disease: Is insulin resistance the link?
inferredcites →https://doi.org/10.1016/j.orcp.2013.08.003openalex-snapshot
Non-alcoholic fatty liver disease in obese children and the relationship between metabolic syndrome criteria
inferredcites →https://doi.org/10.1016/j.patrec.2005.10.010openalex-snapshot
An introduction to ROC analysis
inferredcites →https://doi.org/10.1016/j.ramb.2012.10.004openalex-snapshot
Doença hepática gordurosa não alcoólica e sua relação com a síndrome metabólica no pré-operatório de pacientes submetidos à cirurgia bariátrica
inferredcites →https://doi.org/10.1016/j.ultrasmedbio.2010.07.005openalex-snapshot
Controlled Attenuation Parameter (CAP): A Novel VCTE™ Guided Ultrasonic Attenuation Measurement for the Evaluation of Hepatic Steatosis: Preliminary Study and Validation in a Cohort of Patients with Chronic Liver Disease from Various Causes
inferredcites →https://doi.org/10.1016/s2255-4823(13)70449-1openalex-snapshot
Nonalcoholic fatty liver disease and its association with metabolic syndrome in the preoperative period in patients undergoing bariatric surgery
inferredcites →https://doi.org/10.1038/jhh.2015.67openalex-snapshot
Metabolic syndrome is associated with left ventricular dilatation in primary hypertension
inferredcites →https://doi.org/10.1038/nrgastro.2013.149openalex-snapshot
From NAFLD to NASH to cirrhosis—new insights into disease mechanisms
inferredcites →https://doi.org/10.1038/sj.jhh.1002103openalex-snapshot
Non-esterified fatty acids and blood pressure elevation: a mechanism for hypertension in subjects with obesity/insulin resistance?
inferredcites →https://doi.org/10.1089/met.2014.0117openalex-snapshot
The Complex Association of Metabolic Syndrome and Its Components with Computed Tomography–Determined Emphysema Index
inferredcites →https://doi.org/10.1093/gastro/got007openalex-snapshot
Update of liver fibrosis and steatosis with transient elastography (Fibroscan)
inferredcites →https://doi.org/10.1097/meg.0b013e32834b8d52openalex-snapshot
Nonalcoholic fatty liver disease is associated with blood pressure in hypertensive and nonhypertensive individuals from the general population with normal levels of alanine aminotransferase
inferredcites →https://doi.org/10.1111/cen.12168openalex-snapshot
Low serum potassium level is associated with nonalcoholic fatty liver disease and its related metabolic disorders
inferredcites →https://doi.org/10.1111/j.1440-1746.2007.05042.xopenalex-snapshot
How common is non‐alcoholic fatty liver disease in the Asia–Pacific region and are there local differences?
inferredcites →https://doi.org/10.1111/j.1478-3231.2012.02781.xopenalex-snapshot
Controlled Attenuation Parameter (CAP): a noninvasive method for the detection of hepatic steatosis based on transient elastography
inferredcites →https://doi.org/10.1111/liv.12619openalex-snapshot
High prevalence of non‐alcoholic fatty liver disease in the Chinese – results from the Hong Kong liver health census
inferredcites →https://doi.org/10.1159/000282088openalex-snapshot
The Role of Non-Alcoholic Fatty Liver Disease in Cardiovascular Disease
inferredcites →https://doi.org/10.1186/s12889-015-1927-7openalex-snapshot
The influence of family history of Hypertension on disease prevalence and associated metabolic risk factors among Sri Lankan adults
inferredcites →https://doi.org/10.1530/joe-13-0201openalex-snapshot
Inflammation as a potential link between nonalcoholic fatty liver disease and insulin resistance
inferredcites →https://doi.org/10.1631/jzus.b1400028openalex-snapshot
Association between non-alcoholic fatty liver disease and arterial stiffness in the non-obese, non-hypertensive, and non-diabetic young and middle-aged Chinese population
inferredcites →https://doi.org/10.2147/ott.s78903openalex-snapshot
Validation of the Memorial Sloan Kettering Cancer Center nomogram for predicting non-sentinel lymph node metastasis in sentinel lymph node-positive breast-cancer patients
inferredcites →https://doi.org/10.2337/diacare.28.7.1769openalex-snapshot
Risks for All-Cause Mortality, Cardiovascular Disease, and Diabetes Associated With the Metabolic Syndrome
inferredcites →https://doi.org/10.3748/wjg.v19.i32.5334openalex-snapshot
Prevalence and features of fatty liver detected by physical examination in Guangzhou
inferredcites →https://doi.org/10.3748/wjg.v20.i16.4702openalex-snapshot
Controlled attenuation parameter for non-invasive assessment of hepatic steatosis in Chinese patients
inferredcites →https://doi.org/10.3748/wjg.v20.i26.8407openalex-snapshot
Nonalcoholic fatty liver disease and cardiovascular disease
inferredcites →https://doi.org/10.3748/wjg.v20.i30.10585openalex-snapshot
Diagnostic value of controlled attenuation parameter for liver steatosis in patients with chronic hepatitis B
inferredcites →https://doi.org/10.3785/j.issn.1008-9292.2014.09.010openalex-snapshot
[The association between body mass index and non-alcoholic fatty liver disease].
inferredcites →https://doi.org/10.4066/amj.2013.1648openalex-snapshot
Primary non-alcoholic fatty liver disease in hypertensive patients
inferredcites →https://doi.org/10.5935/abc.20130210openalex-snapshot
Cystatin C, CRP, Log TG/HDLc and Metabolic Syndrome are Associated with Microalbuminuria in Hypertension
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.2139/ssrn.4826078openalex-extracted
Liver Stiffness, Liver Function and Subsequent Metabolic Syndrome in NAFLD Associated Subclinical Atherosclerosis: Perspective from Mediation Analysis
inferred← citeshttps://doi.org/10.1002/jhbp.678openalex-snapshot
Decrease in major secondary bile acid, hyodeoxycholic acid, was the main alteration in hepatic bile acid compositions in a hypertensive nonalcoholic fatty liver disease model
inferred← citeshttps://doi.org/10.1016/j.clinre.2022.101951openalex-snapshot
The prevalence of nonalcoholic fatty liver disease in Chinese adults screened by vibration controlled transient elastography and its diagnostic discrepancy compared with ultrasound
inferred← citeshttps://doi.org/10.1016/j.jceh.2022.01.007openalex-snapshot
Quantitative Ultrasound Assessment of Hepatic Steatosis
inferred← citeshttps://doi.org/10.1016/j.jhep.2025.08.017openalex-snapshot
Effect of hypertension on long-term adverse clinical outcomes and liver fibrosis progression in MASLD
inferred← citeshttps://doi.org/10.1038/s41569-026-01257-zopenalex-snapshot
HFpEF and MASLD: converging mechanisms and clinical implications
inferred← citeshttps://doi.org/10.1080/07315724.2017.1339644openalex-snapshot
The Effects of Ramadan Fasting on Body Composition, Blood Pressure, Glucose Metabolism, and Markers of Inflammation in NAFLD Patients: An Observational Trial
inferred← citeshttps://doi.org/10.1080/21655979.2021.1933302openalex-snapshot
The association between hypertension and nonalcoholic fatty liver disease (NAFLD): literature evidence and systems biology analysis
inferred← citeshttps://doi.org/10.1097/cd9.0000000000000113openalex-snapshot
Overview of the Association Between Non-Alcoholic Fatty Liver Disease and Hypertension
inferred← citeshttps://doi.org/10.1097/cm9.0000000000002111openalex-snapshot
Severity of non-alcoholic fatty liver disease is a risk factor for developing hypertension from prehypertension
inferred← citeshttps://doi.org/10.1097/md.0000000000026415openalex-snapshot
A nomogram incorporated lifestyle indicators for predicting nonalcoholic fatty liver disease
inferred← citeshttps://doi.org/10.1097/meg.0000000000001191openalex-snapshot
Non-alcoholic fatty liver disease and hypertension: coprevalent or correlated?
inferred← citeshttps://doi.org/10.1111/jgh.15005openalex-snapshot
Effects of constant light exposure on sphingolipidomics and progression of NASH in high‐fat‐fed rats
inferred← citeshttps://doi.org/10.1136/bmjopen-2025-099668openalex-snapshot
Association between blood pressure and metabolic dysfunction-associated fatty liver disease among adults without hypertension: a cross-sectional analysis of the National Health and Nutrition Examination Survey 2017–2018
inferred← citeshttps://doi.org/10.1139/cjpp-2025-0176openalex-snapshot
Association of blood pressure with nonalcoholic fatty liver disease defined by fatty liver index
inferred← citeshttps://doi.org/10.1177/00033197221091317openalex-snapshot
Atherosclerosis and Non-Alcoholic Fatty Liver Disease
inferred← citeshttps://doi.org/10.1177/20552076241233135openalex-snapshot
Identifying metabolic dysfunction-associated steatotic liver disease in patients with hypertension and pre-hypertension: An interpretable machine learning approach
inferred← citeshttps://doi.org/10.1186/s12872-025-04744-2openalex-snapshot
The relationship between hepatic steatosis index and hypertension: NHANES 2011–2018
inferred← citeshttps://doi.org/10.1186/s12944-019-1112-6openalex-snapshot
Atherogenic index of plasma is a novel and strong predictor associated with fatty liver: a cross-sectional study in the Chinese Han population
inferred← citeshttps://doi.org/10.1186/s12944-021-01560-3openalex-snapshot
Comparison of obesity-related indices for identifying nonalcoholic fatty liver disease: a population-based cross-sectional study in China
inferred← citeshttps://doi.org/10.1371/journal.pone.0243846openalex-snapshot
The antihypertensive agent hydralazine reduced extracellular matrix synthesis and liver fibrosis in nonalcoholic steatohepatitis exacerbated by hypertension
inferred← citeshttps://doi.org/10.14309/ajg.0000000000000193openalex-snapshot
An AGTR1 Variant Worsens Nonalcoholic Fatty Liver Disease and the Metabolic Syndrome
inferred← citeshttps://doi.org/10.21203/rs.3.rs-328803/v1openalex-snapshot
WHtR may be a Better and Stronger Indictor for Fatty Liver: A Population-Based Cross-sectional Comparison Study of Anthropometric and Metabolic Indices for Identification Fatty Liver in China
inferred← citeshttps://doi.org/10.21275/art20175331openalex-snapshot
Impact of Co-Morbidities in Non Alcoholic Fatty Liver Disease among Type 2 Diabetes Mellitus
inferred← citeshttps://doi.org/10.2174/0929867331666230821095329openalex-snapshot
A Golden Shield: The Protective Role of Curcumin against Liver Fibrosis
inferred← citeshttps://doi.org/10.30699/ijp.2017.25038openalex-snapshot
Clinical Manifestations and Diagnosis of Non-Alcoholic Fatty Liver Disease
inferred← citeshttps://doi.org/10.31146/1682-8658-ecg-230-10-62-70openalex-snapshot
Non-alcoholic fatty liver disease and hypertension: a bidirectional, mutually aggravating relationship
inferred← citeshttps://doi.org/10.33160/yam.2017.06.006openalex-snapshot
Risk Assessment of Hepatocellular Carcinoma in General Population by Liver Stiffness in Combination with Controlled Attenuation Parameter using Transient Elastography: A Cross Sectional Study
inferred← citeshttps://doi.org/10.3346/jkms.2020.35.e198openalex-snapshot
Elevated Alanine Aminotransferase in Early Pregnancy and Subsequent Development of Gestational Diabetes and Preeclampsia
inferred← citeshttps://doi.org/10.3390/biomedicines11092465openalex-snapshot
Which Comes First, Nonalcoholic Fatty Liver Disease or Arterial Hypertension?
inferred← citeshttps://doi.org/10.3390/biomedicines12081739openalex-snapshot
Assessment of the Liver Steatosis and Fibrosis Risk in Metabolic Syndrome and Its Individual Components, Considering the Varying Definitions Used in Clinical Practice throughout Time: A Retrospective Cross-Sectional Study
inferred← citeshttps://doi.org/10.3390/jcdd9120419openalex-snapshot
Comprehensive Review of Cardiovascular Disease Risk in Nonalcoholic Fatty Liver Disease
inferred← citeshttps://doi.org/10.3390/jcm13226976openalex-snapshot
Blood Pressure Patterns and Hepatosteatosis: Cardiometabolic Risk Assessment in Dipper and Non-Dipper Phenotypes
inferred← citeshttps://doi.org/10.3390/jcm9040948openalex-snapshot
Changes in Office Blood Pressure Control, Augmentation Index, and Liver Steatosis in Kidney Transplant Patients after Successful Hepatitis C Infection Treatment with Direct Antiviral Agents
inferred← citeshttps://doi.org/10.3390/nu14245344openalex-snapshot
Ideal Cardiovascular Health Metrics Are Associated with Reduced Severity of Hepatic Steatosis and Liver Fibrosis Detected by Transient Elastography
inferred← citeshttps://doi.org/10.3390/nu9091018openalex-snapshot
Combination of Hypertension Along with a High Fat and Cholesterol Diet Induces Severe Hepatic Inflammation in Rats via a Signaling Network Comprising NF-κB, MAPK, and Nrf2 Pathways
inferred← citeshttps://doi.org/10.37080/nmj.150openalex-snapshot
Study of Sonographically Diagnosed Non-Alcoholic Fatty Liver Disease and Association with its Risk Factors in Nepal Police Hospital
inferred← citeshttps://doi.org/10.4070/kcj.2019.0379openalex-snapshot
A Close Relationship between Non-Alcoholic Fatty Liver Disease Marker and New-Onset Hypertension in Healthy Korean Adults
inferred← citeshttps://doi.org/10.47203/ijch.2022.v34i01.002openalex-snapshot
Non-Alcoholic Fatty Liver Disease and other Non-Communicable Diseases: Time for an Integrated Approach
inferred← citeshttps://doi.org/10.5114/ceh.2019.87635openalex-snapshot
Prevalence and risk factors of non-alcoholic fatty liver disease in southwest Iran: a population-based case-control study
inferred← citeshttps://doi.org/10.5772/intechopen.76199openalex-snapshot
The Role of Cholesterol in the Pathogenesis of Hypertension- Associated Nonalcoholic Steatohepatitis
inferred← citeshttps://doi.org/10.5812/hepatmon-131523openalex-snapshot
Risk Factors of Non-alcoholic Fatty Liver Disease in the Iranian Adult Population: A Systematic Review and Meta-analysis
inferred← citeshttps://doi.org/10.6084/m9.figshare.16780854openalex-snapshot
Additional file 1 of Comparison of obesity-related indices for identifying nonalcoholic fatty liver disease: a population-based cross-sectional study in China
inferred← citeshttps://doi.org/10.6084/m9.figshare.16780857openalex-snapshot
Additional file 2 of Comparison of obesity-related indices for identifying nonalcoholic fatty liver disease: a population-based cross-sectional study in China
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.